| FMRP targets distinct mRNA sequence elements to regulate protein expression M Ascano, N Mukherjee, P Bandaru, JB Miller, JD Nusbaum, DL Corcoran, ... Nature 492 (7429), 382-386, 2012 | 765 | 2012 |
| A human B‐cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers C Lefebvre, P Rajbhandari, MJ Alvarez, P Bandaru, WK Lim, M Sato, ... Molecular systems biology 6 (1), 377, 2010 | 436 | 2010 |
| Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition M Hafner, KEA Max, P Bandaru, P Morozov, S Gerstberger, M Brown, ... Rna 19 (5), 613-626, 2013 | 203 | 2013 |
| Deconstruction of the Ras switching cycle through saturation mutagenesis P Bandaru, NH Shah, M Bhattacharyya, JP Barton, Y Kondo, JC Cofsky, ... Elife 6, e27810, 2017 | 120 | 2017 |
| Association of radiation therapy with risk of adverse events in patients receiving immunotherapy: a pooled analysis of trials in the US food and drug administration database MS Anscher, S Arora, C Weinstock, A Amatya, P Bandaru, C Tang, ... JAMA oncology 8 (2), 232-240, 2022 | 80 | 2022 |
| The interdependent activation of Son-of-Sevenless and Ras P Bandaru, Y Kondo, J Kuriyan Cold Spring Harbor perspectives in medicine 9 (2), a031534, 2019 | 64 | 2019 |
| A saturation-mutagenesis analysis of the interplay between stability and activation in Ras F Hidalgo, LM Nocka, NH Shah, K Gorday, NR Latorraca, P Bandaru, ... Elife 11, e76595, 2022 | 16 | 2022 |
| Mass conservation and inference of metabolic networks from high-throughput mass spectrometry data P Bandaru, M Bansal, I Nemenman Journal of Computational Biology 18 (2), 147-154, 2011 | 10 | 2011 |
| Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune … PJ Vellanki, S Marur, P Bandaru, PS Mishra-Kalyani, K By, A Girvin, ... Journal of Clinical Oncology 38 (15_suppl), 6509-6509, 2020 | 8 | 2020 |
| Impact of radiotherapy on risk of adverse events in patients receiving immunotherapy: A US Food and Drug Administration pooled analysis. MS Anscher, S Arora, C Weinstock, R Lubitz, A Amatya, M Fiero, S Tang, ... Journal of Clinical Oncology 38 (15_suppl), 3018-3018, 2020 | 2 | 2020 |
| Impact of timing of antibiotic use on clinical outcomes in patients with urothelial cancer treated with immune checkpoint inhibitors (ICIs). C Weinstock, P Bandaru, LL Fernandes, E Chang, A Girvin, S Tang, ... Journal of Clinical Oncology 38 (15_suppl), 5045-5045, 2020 | 2 | 2020 |
| Pain medication use in patients with HR+, HER2-neg advanced breast cancer treated with endocrine therapy and a CDK 4/6 inhibitor: A US FDA pooled analysis. JJ Gao, B King-Kallimanis, C Hodgdon, J Cheng, M Fiero, P Bandaru, ... Journal of Clinical Oncology 38 (15_suppl), e24145-e24145, 2020 | | 2020 |
| Patient-reported pain and pain medication impact in patients with HR+ Her2-neg advanced breast cancer: A US FDA pooled analysis. B King-Kallimanis, JJ Gao, C Hodgdon, P Bandaru, A Girvin, C Osgood, ... Journal of Clinical Oncology 38 (15_suppl), e13027-e13027, 2020 | | 2020 |
| Deconstruction of the Ras switching cycle through saturation mutagenesis reveals hot-spots of allosteric activation P Bandaru, J Kuriyan, R Ranganathan PROTEIN SCIENCE 26, 79-79, 2017 | | 2017 |
| Evolutionary constraints on the sequence of Ras P Bandaru University of California, Berkeley, 2017 | | 2017 |
| Identification of mRNAs bound and regulated by human LIN28 M Hafner, KEA Max, P Bandaru | | |
Markus HafnerSenior Investigator, NIAMS, National Institutes of HealthVerified email at nih.gov
